SEC Form 6-K Summary
Business Context and Reporting Period
Medirom Healthcare Technologies Inc., a Japan-based foreign private issuer, filed this Form 6-K for January 2022. The report was filed on January 21, 2022 and concerns a Nasdaq listing-compliance notification received on January 18, 2022.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
Material Change Versus Prior Period
Nasdaq notified the Company that it was not in compliance with the minimum market value requirement for continued listing on The Nasdaq Capital Market. The deficiency was based on the Company’s market value remaining below the required level for 30 consecutive business days, from November 23, 2021 through January 14, 2022.
- Nasdaq Listing Rule 5550(b)(2) requires a minimum market value of $35 million.
- The notification does not immediately affect the Company’s Nasdaq listing.
- The Company was granted 180 calendar days, until July 18, 2022, to regain compliance.
Outlook, Risks, and Unusual Items
The principal risk is potential loss of Nasdaq listing if the Company does not regain compliance by the deadline or obtain any available additional relief. The filing does not state a remediation plan or provide financial guidance. It includes customary forward-looking statement disclosures, noting that future plans and performance are subject to significant uncertainties and contingencies.
Investor Verification Checklist
- Verify whether the Company regained compliance with Nasdaq’s minimum market value requirement by July 18, 2022.
- Review subsequent filings for any Nasdaq extension, appeal, delisting notice, or listing-status update.
- Assess the Company’s market capitalization, share price, liquidity, and capital position in subsequent financial reports.
- Review the Company’s forward-looking statements and any disclosed remediation actions.